Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Tolerability”

1,903 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,903 results

Early research (Phase 1)Study completedNCT04634149
What this trial is testing

Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment

Who this might be right for
Moderate Liver ImpairmentSevere Liver Impairment
Bristol-Myers Squibb 16
Not applicableStudy completedNCT04555447
What this trial is testing

Gastrointestinal Tolerability to Agavins and Impact on Host-gut Microbiota-metabolism Interactions Modulation

Who this might be right for
ObesityHealthy
Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional-Unidad Irapuato 52
Early research (Phase 1)Active Not RecruitingNCT06532331
What this trial is testing

A PhaseⅠStudy of ONO-7475 in Combination With ONO-4538 and Gemcitabine Plus Nab-paclitaxel (GnP), the Standard of Care, and ONO-7475 in Combination With GnP in Patients With Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Ono Pharmaceutical Co., Ltd. 87
Testing effectiveness (Phase 2)Looking for participantsNCT06959615
What this trial is testing

A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration

Who this might be right for
Advanced Solid Tumor
Jacobio Pharmaceuticals Co., Ltd. 334
Testing effectiveness (Phase 2)Study completedNCT04685993
What this trial is testing

The Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Lipocine Inc. 25
Testing effectiveness (Phase 2)Looking for participantsNCT07636785
What this trial is testing

And 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

Who this might be right for
Hepatocellular Carcinoma (HCC)Metastatic Uveal MelanomaRenal Cell Carcinoma (RCC)+2 more
VM Discovery, Inc. 111
Testing effectiveness (Phase 2)Study completedNCT04000139
What this trial is testing

Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
University of Zurich 48
Early research (Phase 1)Study completedNCT01081483
What this trial is testing

Single Doses of ABT-072 in Japanese Healthy Male Adults

Who this might be right for
Hepatitis C
Abbott 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05595473
What this trial is testing

Evaluate the Safety, Tolerability and Efficacy of RZ-001 with Valganciclovir (VGCV) in Subjects with Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Rznomics, Inc. 42
Early research (Phase 1)Study completedNCT05327231
What this trial is testing

IN10018 Monotherapy or in Combination With Docetaxel in Gastric or GEJ Adenocarcinoma

Who this might be right for
Gastric Cancer
InxMed (Shanghai) Co., Ltd. 33
Testing effectiveness (Phase 2)Ended earlyNCT00329537
What this trial is testing

Study of Sargramostim in Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Genzyme, a Sanofi Company 11
Testing effectiveness (Phase 2)Study completedNCT03155945
What this trial is testing

Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal Pain

Who this might be right for
Crohn's DiseaseAbdominal Pain
Arena Pharmaceuticals 14
Early research (Phase 1)Looking for participantsNCT06764316
What this trial is testing

A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Bayer 148
Large-scale testing (Phase 3)Active Not RecruitingNCT04167358
What this trial is testing

Linerixibat Long-term Safety, and Tolerability Study

Who this might be right for
Cholestasis
GlaxoSmithKline 242
Large-scale testing (Phase 3)Study completedNCT02185014
What this trial is testing

Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115

Who this might be right for
Crohn's Disease
AbbVie 252
Early research (Phase 1)Ended earlyNCT05423106
What this trial is testing

A Single and Multiple Ascending Dose Study of JNJ-64457744

Who this might be right for
HealthyHepatitis B, Chronic
Janssen Research & Development, LLC 60
Early research (Phase 1)Ended earlyNCT01822756
What this trial is testing

An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsPancreatic Cancer
Incyte Corporation 42
Early research (Phase 1)Study completedNCT04926701
What this trial is testing

A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD001 in Healthy Subjects

Who this might be right for
Cystic Fibrosis
Enterprise Therapeutics Ltd 98
Not applicableStudy completedNCT04147936
What this trial is testing

Study of the Safety and Tolerability of AXA1665 in Subjects With Mild and Moderate Hepatic Insufficiency

Who this might be right for
Hepatic Insufficiency
Axcella Health, Inc 60
Early research (Phase 1)Study completedNCT00906256
What this trial is testing

Clinical Pharmacology Study of AZD7295 in Healthy Subjects

Who this might be right for
Healthy
Arrow Therapeutics 16
Next Page